Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

[Clinicopathological and prognostic analysis of primary clear cell carcinoma of the liver].

Li ZY, Bi XY, Zhao JJ, Zhao H, Zhou JG, Huang Z, Cai JQ, Zheng XC.

Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):140-3. doi: 10.3760/cma.j.issn.0253-3766.2013.02.015. Chinese.

PMID:
23714671
2.

Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.

Li T, Fan J, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY.

Ann Surg Oncol. 2011 Jul;18(7):1955-63. doi: 10.1245/s10434-010-1540-z. Epub 2011 Jan 15.

PMID:
21240562
3.

[Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].

Li Z, Huang Z, Bi X, Yang L, Zhao J, Zhao H, Zhang Y, Cai J, Zheng X.

Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):207-11. Chinese.

PMID:
24785282
4.

[Diagnosis and treatment of primary clear cell carcinoma of the liver].

Ye XP, Li LQ, Peng T, Xiao KY, Su ZX, Shang LM, Su M, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):64-6. Chinese.

PMID:
20211073
5.
6.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

7.

[A clinicopathological and prognostic study of rare pathological subtype cases of hepatocellular carcinoma].

Li Z, Bi X, Yang L, Zhao J, Zhao H, Huang Z, Cai J, Zheng X.

Zhonghua Wai Ke Za Zhi. 2014 May;52(5):329-32. Chinese.

PMID:
25034737
8.

[Prognosis of hepatocellular carcinoma: a study of 832 cases].

Yan T, Zhao JJ, Bi XY, Zhao H, Huang Z, Li ZY, Zhou JG, Li Y, Li C, Cai JQ, Zhao P.

Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):54-8. doi: 10.3760/cma.j.issn.0253-3766.2013.01.012. Chinese.

PMID:
23648302
9.

Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.

Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF.

J Gastrointest Surg. 2009 Sep;13(9):1627-35. doi: 10.1007/s11605-009-0933-4. Epub 2009 Jun 9.

PMID:
19506976
10.

Clinicopathological and prognostic features of primary clear cell carcinoma of the liver.

Liu Z, Ma W, Li H, Li Q.

Hepatol Res. 2008 Mar;38(3):291-9. Epub 2007 Sep 17.

PMID:
17877725
11.

Therapy and prognostic features of primary clear cell carcinoma of the liver.

Ji SP, Li Q, Dong H.

World J Gastroenterol. 2010 Feb 14;16(6):764-9.

12.
13.

Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.

Zhang XF, Yin ZF, Wang K, Zhang ZQ, Qian HH, Shi LH.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23.

14.

Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.

Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.

J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.

PMID:
19197197
15.

Primary clear cell carcinoma of liver--clinicopathologic features and surgical results of 18 cases.

Lao XM, Zhang YQ, Jin X, Lin XJ, Guo RP, Li GH, Li JQ.

Hepatogastroenterology. 2006 Jan-Feb;53(67):128-32.

PMID:
16506391
16.

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J.

Am J Gastroenterol. 2001 Apr;96(4):1243-50.

PMID:
11316177
17.

Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series.

Bège T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, Garcia S.

J Gastrointest Surg. 2007 May;11(5):619-25.

PMID:
17468920
18.

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.

Choi D, Lim HK, Rhim H, Kim YS, Yoo BC, Paik SW, Joh JW, Park CK.

Ann Surg Oncol. 2007 Aug;14(8):2319-29. Epub 2007 May 24.

PMID:
17522947
19.

Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.

Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT, Xu MQ, Yang JY.

World J Gastroenterol. 2013 Mar 21;19(11):1811-9. doi: 10.3748/wjg.v19.i11.1811.

20.

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.

Du M, Chen L, Zhao J, Tian F, Zeng H, Tan Y, Sun H, Zhou J, Ji Y.

BMC Cancer. 2014 Jan 24;14:38. doi: 10.1186/1471-2407-14-38.

Items per page

Supplemental Content

Write to the Help Desk